Cargando…
Cost-effectiveness of different treat-to-target strategies in rheumatoid arthritis: results from the DREAM registry
BACKGROUND: Adjusting medication of patients with rheumatoid arthritis (RA) until predefined disease activity targets are met, i.e. Treat-to-Target (T2T), is the currently recommended treatment approach. However, not much is known about long-term cost-effectiveness of different T2T strategies. We mo...
Autores principales: | van de Laar, Celine J., Oude Voshaar, Martijn A. H., Vonkeman, Harald E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487515/ https://www.ncbi.nlm.nih.gov/pubmed/31168521 http://dx.doi.org/10.1186/s41927-019-0064-9 |
Ejemplares similares
-
Recently diagnosed rheumatoid arthritis patients benefit from a treat-to-target strategy: results from the DREAM registry
por: Steunebrink, Laura M. M., et al.
Publicado: (2016) -
Treating to the target of remission in early rheumatoid arthritis is cost-effective: results of the DREAM registry
por: Vermeer, Marloes, et al.
Publicado: (2013) -
Radiographic progression in early rheumatoid arthritis patients following initial combination versus step-up treat-to-target therapy in daily clinical practice: results from the DREAM registry
por: Steunebrink, Laura M. M., et al.
Publicado: (2018) -
Radiographic progression can still occur in individual patients with low or moderate disease activity in the current treat-to-target paradigm: real-world data from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry
por: ten Klooster, Peter M., et al.
Publicado: (2019) -
Adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the DREAM remission induction cohort
por: Vermeer, Marloes, et al.
Publicado: (2012)